NASDAQ (USD): Protara Therapeutics, Inc. (TARA)
Last Price
5.50
Today's Change
0.00 (0.00%)
Day's Change
5.40 - 5.57
Trading Volume
110,339
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US New-home Sales Rebound in November After Storm-stricken Month
2
Orders for US Business Equipment Rise by Most in Over a Year
3
Biden Launches New US Trade Probe Into Legacy Chinese Chips
4
Google to Fight Japan’s Claims That It Hobbles Rivals in Search
5
Musk Makes ‘overstaffed’ US Fed Target in Quest for Efficiency
#
Stock
Score
INTZ
Intrusion Inc.
ZCAR
Zoomcar Holdings, Inc.
BABA
Alibaba Group Holding Limited
850
AAPL
Apple Inc.
800
AGN
750
6
SOXL
Direxion Daily Semiconductor Bull 3X Shares
7
PLTR
Palantir Technologies Inc.
8
WDC
Western Digital Corporation
500
9
NICE
NICE Ltd.
10
SCHD
Schwab U.S. Dividend Equity ETF
Last
Change
Volume
AILE
0.678
+0.517
285,826,786
LICN
0.489
-1.631
183,350,854
QUBT
15.14
-10.54
120,604,778
LMDX
0.016
-0.018
120,553,903
RGTI
16.149
+0.719
114,894,761
QSI
3.05
+0.901
113,191,712
LILM
0.209
-0.334
112,784,715
XTIA
0.042
+0.002
92,648,822
MU
87.09
-16.81
87,924,604
NVDA
762.00
-84.71
85,558,284
BRK-A
688,109.28
+509.25
460
NVR
8,299.799
+55.81
1,684
AZO
3,253.14
+11.89
5,500
QMCO
74.39
+7.02
2,792,817
CBO
29.53
+6.81
100
PNRG
232.30
+5.30
4,303
AMED
89.55
+3.60
820,566
ROG
107.65
+3.59
53,827
VIXY
45.33
+3.52
598,921
VXX
46.02
+3.47
1,332,113
MELI
1,774.05
-343.25
2,940,447
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
BKNG
5,036.20
-59.84
14,566
FNGU
609.56
-50.86
307,063
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....